PBYI FY 2009 Earnings — Puma Biotechnology, Inc. Revenue & Financial Results | Market Cap Arena

PBYIPuma Biotechnology, Inc.

$300M

FY 2009 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$16,836

Net Income

-$16,836

EPS (Diluted)

$-0.01

Cash Flow

Operating Cash Flow

-$16,815

Free Cash Flow

-$16,815

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$2,408

Total Liabilities

$2,270

Stockholders' Equity

$138

Cash & Equivalents

$2,408

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	$0	—
Operating Income	-$16,836	-$14,083	-19.5%
Net Income	-$16,836	-$14,083	-19.5%